Research / RIVN / Fundamental state Inspectable configuration
State dimensions Filing 0001874178-24-000014 General Corporate
Debt relative to revenue 13th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.debt_to_revenue
99.93% · OPTIONAL · VALID
Capex intensity 25th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.capex_revenue_ratio
23.14% · OPTIONAL · VALID
Operating cash generation 88th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-109.74% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
167.43% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 0th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
59.09% · OPTIONAL · VALID
Gross margin 78th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.gross_margin
-45.78% · CORE · VALID
Operating margin 78th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.operating_margin
-129.43% · CORE · VALID
R&D intensity 22th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
44.99% · OPTIONAL · VALID
SBC intensity 25th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
18.52% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 20 states Self-history eligible
Sep 30, 2021 0/4 normalized Level 3 Dec 31, 2021 0/8 normalized Level 3 Mar 31, 2022 0/8 normalized Level 3 Jun 30, 2022 0/8 normalized Level 3 Sep 30, 2022 0/9 normalized Level 3 Dec 31, 2022 0/9 normalized Level 3 Mar 31, 2023 0/9 normalized Level 3 Jun 30, 2023 0/9 normalized Level 3 Sep 30, 2023 4/9 normalized Level 3 Dec 31, 2023 8/9 normalized Level 3 Mar 31, 2024 8/9 normalized Level 3 Jun 30, 2024 8/9 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 203.44%
Current 99.93%
Delta -103.51% Capex Intensity Increased
Previous 14.21%
Current 23.14%
Delta 8.93% Cash Generation Decreased
Previous -65.59%
Current -109.74%
Delta -44.15% Growth Increased
Previous 149.44%
Current 167.43%
Delta 17.99% Inventory Pressure Decreased
Previous 189.23%
Current 59.09%
Delta -130.14% Margin Decreased
Previous -35.68%
Current -45.78%
Delta -10.11% Profitability Decreased
Previous -107.70%
Current -129.43%
Delta -21.73% R And D Intensity Increased
Previous 39.57%
Current 44.99%
Delta 5.43% Sbc Intensity Increased
Previous 18.10%
Current 18.52%
Delta 0.42% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.